RxDoctor Payments Data

Shie-Pon Tzung

Gastroenterology · Bellevue, WANPI 1023096252

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $12,140 of the $16,017 with a category attached, or 75.8%. Gilead accounts for 88.7% of it on its own, with 19 other manufacturers making up the rest. Reporting peaked in 2019 at $13,825 and has fallen 96.3% since, to $515 in 2021. Among gastroenterology clinicians in WA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$16,017in general payments, 2019–2025

Across 146 payments — averaging $109.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Gilead$14K
  • AbbVie$467
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$328
  • Takeda Pharmaceuticals U.S.A., Inc.$233
  • Pfizer$175
  • Johnson & Johnson$120
  • plus $480 from 14 others

What the payments were for

  • Speaking & faculty fees$12,14076%
  • Travel & lodging$1,1207%
  • Food & beverage$2,75717%

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$16,017 in reported general payments places this provider in the 90th percentile of 447 gastroenterology providers in Washington.

See all gastroenterology providers in Washington

Other gastroenterology in Bellevue

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →